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Background: The estimated number of in-hospitals deaths due to adverse events is often different when using
data from deceased patients compared with that of a population experiencing adverse events.
Methods: The study was conducted at three hospitals in the Bergen Hospital Trust, including a 950-bed university
hospital. The objective was to study the reported deaths and investigate the probable number of deaths caused by
adverse events. Information about all patients who died in the hospitals during 2011 was retrieved from the
electronic patient data management system and the medical records. All deaths were classified into two groups
according to Norwegian law based on whether or not the death was sudden and/or unexpected. The cause of
death in the latter group was further classified as being due to either natural or unnatural causes according to
national requirements. An expert review panel screened the patient records for information regarding adverse
events and possible (≥ 50%) preventability. Age, length of hospital stay, and Charlson Comorbidity Index were
also registered.
Results: There were 59,605 unique patients admitted in 2011 and 1185 registered deaths (1.98%). The mean and
median ages of the deceased were 73,8 and 78 years, respectively, and the median length of stay was 5.6 days
(range). Of these deaths, 290 (24.5%) were considered sudden and/or unexpected and 218 were considered to be
due to natural causes. Of the 72 unnatural deaths, 16 (1.4%) were classified as preventable or probably preventable.
For 18 deaths (%) it was impossible to confirm or rule out preventability.
Conclusions: Using this method, we identified a small proportion of hospital deaths that could be classified as
unnatural. Furthermore, there was a ≥ 50% chance or more that 34 deaths (2.9%) were due to causes that could
have been prevented.
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Death is a common occurrence in hospitals, partly
because of the increased number of patients with severe
and complicated chronic end-stage diseases and partly
as a consequence of the increased severity of the illness
in many acutely admitted patients. Hospital deaths can
also occur partially or totally as a consequence of* Correspondence: hans.flaatten@kir.uib.no
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magnitude of the latter group is debatable and depends
on what technique is used to identify the events [2].
Recently, two studies from Europe were published that
primarily studied cohorts of patients dying in hospitals
with regards to the contribution of adverse events to
these deaths. In the UK, 1000 deaths in 10 hospitals
were retrospectively reviewed. Of these, 5.2% of the
deaths were judged as preventable [3]. In a similar
investigation from the Netherlands, 3983 admissions of
patients who died in 21 hospitals were studied. In that
study, 4.1% of deceased patients had a preventablele is distributed under the terms of the Creative Commons Attribution 4.0
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similar cohort studies of deceased patients in which the
occurrence of adverse events contributing to hospital
deaths has been described has been performed in any of
the Nordic countries.
The Bergen Hospital Trust, Norway, is composed of
one large regional university hospital and two local hos-
pitals. In order to better understand the occurrence of
hospital deaths in general and, in particular, adverse
events contributing to deaths in our hospitals, we ana-
lysed all hospital deaths that occurred in 2011. The pri-
mary aim was to describe the causes of death in all
deceased patients according to Norwegian law and, in par-
ticular, the group of unexpected deaths that includes
deaths related to treatment of disease or trauma (Table 1).
We also wanted to further investigate those deaths that
could be attributed to an adverse event and whether those
deaths could have been prevented. Furthermore, we
wished to describe the epidemiology of our hospital deaths
with regards to clinical departments, times of death, age,
gender, and co-morbidities of the patients who died.
Methods
Bergen Hospital Trust is the largest health trust in Helse
Vest, the western-most of the four Norwegian health
regions. The main hospital is Haukeland University
Hospital, a 950-bed tertiary referral hospital serving 1.1
million inhabitants (approximately 20% of the Norwegian
population). It is also the local hospital for the 350,000 in-
habitants of Bergen, the second largest city in Norway.
The hospital performs all types of medical services with
the exception of organ transplantation and replantation
surgeries. There is also a small community hospital (Voss)
included in Bergen Hospital Trust and one private com-
munity hospital in the health trust (Haraldsplass DiaconalTable 1 List of unnatural causes of death according to
Norwegian law
Death is considered to be unnatural if it was caused by:
A. Murder or other trauma to the human body
B. Suicide or self-inflicted damage to the body
C Accidents including capsizing, burns, avalanche, lightning strikes,
drowning, traffic-related incidents
D. Occupational accidents
E. Error, omission, or accidents related to diagnosis or treatment of
disease or trauma
F. Use of illegal drugs
G. Unknown causes when death has occurred suddenly and
unexpectedly
H. All deaths occurring in civil or military prisons
I. Finding of an unidentified corpse
This list is the official list of unnatural deaths in Norway (§ 2 Norwegian
Regulations 2000–12-21 nr. 1378)Hospital). Data from all three hospitals were included in
the study.
During 2011, the hospitals treated 59,605 unique in-
patients. In Norway we have no separate Emergency de-
partments, only emergency rooms. Hence all patients
are assigned to one of the hospital departments at ad-
mission. Patients were automatically registered accord-
ing to defined criteria at discharge as alive or dead. The
hospital records (medical files) for all deceased patients
in our hospital trust in 2011 (eligible criteria), were re-
trieved from our electronic administrative and medical
records system (DIPS-EPJ-Distribuert Informasjons og
Pasientdatasystem i Sykehus, an application developed
in Norway). The study size was as such predefined to
this group, n = 1185 hospital deaths.
For all deaths, the patients’ age, gender, date and time
(hour of the day) of death from the hospital admission,
and the department responsible for the patient’s care at
the time of death, were also registered. In addition, the
Charlson Comorbidity Index [5] was calculated using
the 10th revision of the International Statistical
Classification of Diseases and Related Health Problems
(ICD-10) admission primary and secondary diagnoses.
Because of the large amount of records to screen we
used a two stage strategy: an initial screening of all death
records, then an in-depth consensus discussion of the sud-
den and unexpected deaths identified in the first screening.
For the first part of the hospital record screening, four
investigators (HF, RSA, BAA and JHR) independently
screened records of hospital deaths and initially classi-
fied the death as unexpected or not unexpected (Fig. 1).
It is mandatory to document this in official Norwegian
death certificates where a box have to be ticked if the
death is considered unexpected and/or with sudden on-
set. No formal training for this task was done, but two
of the physicians had extensive training in journal
screening through the hospital adverse event reporting
system (hospital auditory committee). Disagreements at
this stage were discussed until a consensus was reached.
If not resolved, the death was classified as an unexpected
death. When the death was classified as sudden or unex-
pected, it was obvious from the medical record that the
patient was not in the final stage of a severe, chronic, or
terminal disease and that death was forthcoming. The
remaining deaths were classified as expected, although
no strict criteria were given for this group of deaths as
they are considered more of an exclusion group for not
being sudden or unexpected according to Norwegian
law. In the end of this stage, when a death was consid-
ered sudden and unexpected, unnatural causes of death
must be accounted for, if present, using a list of specified
conditions defined according to Norwegian law: § 2 in
“Regulation of physicians’ report to the police about
unnatural deaths” 2001 (Table 1), in particular section E.
Fig. 1 Taxonomy regarding all hospital deaths according to
Norwegian regulations
Flaatten et al. BMC Health Services Research  (2017) 17:465 Page 3 of 7In part two, all deaths classified as unnatural were dis-
cussed by a reference group of six consultants from sur-
gery, anaesthesiology and emergency medicine, intensive
care, internal medicine, pathology, and the hospital pa-
tient safety unit during a one-day meeting. No formal
training for this group were done, but we considered it
important that this group represented a broad clinical
experience since some of these deaths are often ex-
tremely difficult to judge in particular with regard to
preventability. Consensus about the causes of unnatural
deaths was sought. In addition, signs of any adverse
event during the hospital stay were discussed and a con-
sensus was reached as to whether or not (≥50% likeli-
hood) the death could have been prevented. To answer
the latter question, a five-point Likert scale was used: 1
was scored as not preventable, 2 as possibly not prevent-
able, 3 as uncertain preventability, 4 as possibly prevent-
able, and 5 as preventable.
MedCalc v 12.7.00 for Windows (MedCalc Software)
was used for comparisons between groups and calcula-
tion of 95% confidence intervals (CI) for mean and me-
dian values. Kaplan Meier curves were produced using
JMP software (SAS Institute Inc).
Ethical approval
The study protocol was approved by the Regional
Research Ethics Committee of the Western Health
Region (2012/564). They judged the study to be a quality
assurance project of existing hospital data and therefore
waived informed consent. The project was also approvedby the data protection officer (personvernombudet)
Bergen Health Trust (2015/566). After extraction of clin-
ical data from the patients’ files and analysis of each
death, all further analysis and group discussions were
performed using de-identifiable data.Results
Most of the recorded 1185 deaths (1.98% of all admis-
sions) occurred in typical “medical departments” such as
the Cardiac, General Medical, or Pulmonary Departments
(Table 2). The median and mean ages of all patients who
died were 78 and 73, 8 years, respectively. There were no
significant differences in deaths throughout the year, but
the time of death during the day peaked around noon
(13–14 h) and in the evening (20–21 h) (Fig. 2). The
median time from admission to death was 5.6 days.
We found 290 (24.5%), unexpected deaths leaving 895
deaths classified as expected (75.5%). Of the 290
unexpected deaths, 72 (6.0% of all deaths) were classified
as unnatural deaths (Table 3) and the remaining were
considered to be due to natural causes. In 16 deaths
(1.4%), we identified evidence of adverse events or fac-
tors that could have been prevented or may have con-
tributed to the death (Table 4). In 18 deaths (1.5%), it
was not possible to determine preventability. This im-
plies that in 34 deaths (2.9%) there was ≥50% likelihood
that death was preventable. Both hospital LOS and CCI
were higher among patients in the group of expected
deaths, and the lowest values were found in the group of
unexpected unnatural deaths. The Kaplan-Meier curves
of hospital stay for the groups of expected or sudden
and unexpected are shown in Fig. 3.
There were differences in the proportion of sudden
and unexpected deaths and also unnatural deaths
according to type of clinical department (Table 2).
Departments of Surgery, Medicine and Cardiology had
the highest proportion of their deaths classified as sud-
den, unexpected and un-natural. The lowest proportions
were found in a mixed group of Departments, with
considerably fewer deaths, as Ophthalmology. ENT,
Neurology, Gynaecology and Obstetric to mention some.
The single unit with the highest proportion was found at
the Department of Neurosurgery with 49% sudden or
unexpected deaths, and 26% considered as un-natural.Discussion
In this study, we found that approximately 2% of all hos-
pital admissions ended with the patient dying during their
hospital stay. The majority of deaths occurred in ordinary
hospital wards, not in the intensive care units or interven-
tion/operating theatres. Approximately one out of four
hospital deaths was considered to be unexpected and/or
sudden. Only a minor proportion of deaths (6%) were
Table 2 Characteristics of patients who died in the hospital
Group N Age (years)





Died in ICU (%)
All 1185 73.8 (78) 6.9 8.4 11.6
Expected 895 74.5 (78) 7.4 (7.2–7.6) 9.1 8.7
Unexpected 290 71.5 (78) 5.5 (5.1–5.8) 8.2 20.3
Natural 218 73.5 (79; 77–81) 5.7 (5.3–6.0) 8.4 18.8
Unnatural 72 66.0 (69; 64–76) 4.8 (4.0–5.5) 7.6 25.7
Patients deaths were classified as expected or unexpected, and as due to natural or unnatural causes. CI confidence interval; CCI Charlson Comorbidity Index;
LOS length of stay; ICU intensive care unit
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have ≥50% likelihood of being preventable.
There are very few published papers about death in
Norwegian hospitals in general. We know from Statistics
Norway that 41.304 citizens in Norway died in 2011, and
that 14,452 (34.9%) of these deaths occurred in hospitals
[6]. Hence, 1189 (8.2%) of all Norwegian in-hospital
deaths occurred in our health trust, which serves ap-
proximately 8% of the population. In a previous study of
496 deaths from a single hospital in Norway in 2008, the
quality of the death certificates was studied prospectively
[7]. Incorrect information was found in 20% of all death
certificates, and 12% of all deaths were due to unnatural
causes; lethal adverse drug reactions comprised 5% of
deaths. Interestingly, a retrospective analysis of deaths
from two previous months that were presented as con-
trols showed that the proportion of unnatural deaths
was 7%, a figure not very different from the 6% found in
our retrospective study. This may indicate that a
prospective analysis at the time of death is a better
approach for exploring the circumstances around unnat-
ural deaths than a retrospective one.
In general, two different methods are used to identify
unnatural causes of death in hospitals. The first is a
traditional method that analyses the patients that die in
either a representative sample or all deaths during aFig. 2 Frequency of deaths according to the hour of the daycertain period. The other is to study a group of patients
exposed to an adverse event and follow their outcome.
Adverse events can be studied in several ways, from
using specific reporting systems to retrospectively
screening patient files. The latter method has become
very popular since its first use in the 1990s and has re-
cently been systematised through the Global Trigger
Tool (GTT) method [8]. In this method, a random sam-
ple of patient hospital files is screened at regular inter-
vals to determine the magnitude and consequences of
adverse events.
The GTT method was introduced in Norway in 2011
and is now routinely used in many Norwegian hospitals [9].
In a recent study from Portugal, the adverse event
screening method was used to estimate the incidence of
adverse events in hospitals and their relevance to hos-
pital deaths [10]. A random sample of 1669 medical re-
cords from three acute care hospitals from 2009 was
analysed using a structured record review based on 18
criteria. The study found an 11.1% incidence of adverse
events, with approximately 50% considered preventable.
Of these, 10.8% were associated with deaths. This means
that approximately 1.2% (20) of their random sample
(12 out of 1000 patients admitted to hospital) died
from an adverse event.
The number of deaths in Norwegian hospitals has also
been estimated using data from the GTT campaign [11].
This project found similar incidences as in Portugal; i.e.,
adverse events contributed to a high proportion (0.66%)
of all hospital admissions leading to death in 2010.
Transformed to all hospital admissions in our country
in 2010, this equates to 4500 deaths or 34% of all
hospital deaths.
This way of estimating hospital deaths seems regularly
to give higher numbers of patients dying from adverse
events than when only the population that actually dies
in the hospital is specifically investigated. There might
be several explanations for this discrepancy. When using
the GTT to investigate random hospital admissions, only
a small proportion of patients reviewed will die during
their hospital stay. Also, the variation from sample to
sample will most likely be large as well as the margin of
error. Such random sample estimations should therefore
Table 3 Differences in number of deaths according to clinical units
Units Number Age (mean) LOS mean SUD (%)# Un-nat (%)#
Surgical 235 74.5 8.4 90 (31) 28 (40)
Medical 349 78.9 8.5 77 (27) 11 (16)
Pulmonary 150 74.3 8.8 20 (7) 4 (6)
Cardiology 183 73.9 5.2 74 (25) 18 (26)
Miscellaneous 268 66.2 9.6 29 (10) 9 (13)
All units 1185 73.8 8.4 290 70
LOS Length of stay, days, CCI Charlson Comorbidity Index, SUD Sudden unexpected death, Un-nat unnatural deaths according to Norwegian law. # % of number
of deaths in the group
In text: The highest proportion of deaths classified as sudden unexpected deaths and unnatural deaths was found in the Department of Neurosurgery (49 and
26% respectively)
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hospital or region with specific regards to the frequency
of adverse events leading to death.
Studies using our methods are infrequently published
from Europe, but have recently been presented from the
UK and the Netherlands. In the Netherlands [4], a large
study from 2008 on adverse events including a large
sample of hospital deaths found evidence of adverse
events in 10.7% of all patients who had died. Of these,
4.1% of the deaths were deemed preventable. In a recent
follow up, deaths due to adverse events in Dutch hospitalsTable 4 Possible preventable events leading to death
Age Event(s) leading to death
85 Pneumonia, ultrasound guided biopsy. Not monitored. Next nigh
and severe hypoxemia. Died. Death probably related to the biop
90 Isoprenaline infusion with a syringe pump. The hosing lost conne
development of therapy resistant bradycardia and death.
60 Admission with suspected endocarditis, not monitored. Had card
64 Elective surgery for liver metastasis. Perioperative lesion of the liv
73 Admitted with tentative diagnosis: urethral stone, and was treate
mortem autopsy revealed peritonitis and perforated colon. Error
80 Whiple’s operation performed. In recovery room delirious, and a
pulmonary aspiration leading to cardiac arrest and death.
77 Urethral catheter inserted which resulted in profound urethral ble
urinary tract infection. Death.
57 Iatrogenic opiate overdose postoperatively. Found dead in bed. P
68 Thoracic drain inserted to remove pleural effusion. After several h
exam revealed large amount of blood in thoracic cage.
64 Postoperative pneumothorax during mechanical ventilation. Inse
leading to thoracotomy because of ongoing bleeding. Had a car
treatment some days later.
80 Pleural drain inserted. Resulted in bleeding and cardiac arrest. Re
66 Cancer pulm. Operated. After surgery airway problems (ET tube)
stopped after 6 days.
60 Abdominal pain, given ketobemidon. Low body weight. Register
found dead in the morning. Possible opioid overdose.
81 Because of delirum given klometiazol (Heminevrin) i.v. One hour
89 17 days in hospital with abdominal pain, no diagnosis made. Pat
of omission
86 Dyspnoe and AMI, given antithrombotic drugs that resulted in prduring 2011–2012 were reported to be further reduced to
2.6% [12]. This is a time-period similar to our study with
comparable results on preventable deaths of 2.9%. In a UK
[3] study of 1000 hospital deaths that occurred in 10 acute
care hospitals, reviewers judged that 5.2% of the deaths
had a ≥ 50% chance of being preventable.
The first application of GTT from 2010 to 2011 in
five Danish hospitals was recently published [13].
Interestingly, and in contrast to the Norwegian safety
campaign study, none of these events was found to lead
to a fatal outcome.t developed signs of septic shock with hypotension, lactate 18 mmol/l
sy.
ction with syringe, and before this was detected the patient
iac arrest on ward, resuscitation efforts negative. Died.
er vein with profuse bleeding. Death on the operating table.
d for this. Patient suddenly developed circulatory arrest and died. Post
of omission.
new gastric tube had to be reinserted. This resulted in vomiting and
eding and hypovolemic shock. Next day severe sepsis secondary to
robably related to opioid overdose.
ours development of circulatory shock and anemia. Died. Post mortem
rtion of pleural drain resulted in bleeding from an intercostal artery,
diac arrest. ROSC, but severe cerebral injury led to withdrawal of
ceived anticoagulation drugs.
with hypoxemia and hypotension. Did not wake up, and treatment was
ed low respiratory rate during next night, nothing was done and patient
later cardiac arrest and with no ROSC. Died.
ient died. Post mortem revealed gallstone and cholecystitis. Error
ofound bleeding and haemorrhagic shock. Death.
Fig. 3 In-hospital survival prior to death in patients whose death
was classified as expected versus unexpected
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consequence is also difficult to determine. Very often,
the observed consequence (effect) of an event is mixed
with the adverse event, making it difficult to separate the
two. As an example, if the adverse event is a miscalcula-
tion in the given dose of a particular drug, the conse-
quences could range from no event (most likely) to
death (very infrequent), but the initial adverse event re-
mains the same. In particular, the link between adverse
events in patients who later expire in the hospital is
challenging to identify. The expertise of the screening
teams may not always be sufficient to evaluate such
events in adequate depth since competence and insight
into the particular medical field is important.
Several of our unnatural deaths occurred in the oper-
ating theatre in patients who were critically ill or who
had near-lethal conditions prior to hospitalisation (e.g.
multiple trauma or cardiac arrest). Critically reviewing
such deaths is extremely difficult in the context of ad-
verse events given the complexity of such situations.
We found that the majority of the deaths in our hos-
pital were expected according to circumstances present
at admittance or that became obvious during the pa-
tients’ hospital stay. Since we do not have a comprehen-
sive hospice system, it is also common for Norwegian
hospitals to admit patients whose death is imminent in
order to provide symptom relief, comfort, and care until
death. In this particular group of patients, we argue that
the use of our traditional understanding of adverse
events could be of limited clinical value. Very often, the
final common path to death from a terminal illness is a
respiratory “complication”, such as aspiration or pneu-
monia, leading to respiratory failure and, in the end, car-
diac or respiratory arrest. Such conditions, although
possibly preventable, do not conform to the concept of
an adverse event that we would necessarily aim to cor-
rect or prevent. Perhaps errors of omission, such asinadequate pain and symptom control, are more import-
ant in this group of patients. However, we did not have
sufficient data to analyse this. This is why the first part
of our study was to document whether or not a death
was expected and, if the cause of death was probable
from the disease process, this was categorised as an
expected death. In our opinion, it is mainly in the group
of unexpected deaths that the term “lethal adverse
event” is clinically meaningful.
As with all retrospective analyses, our study has
several limitations. Necessary and detailed information
about the occurrence of adverse events is not always
documented in the patient files. This is particularly true
for errors of omission. We did not follow a strict
procedure regarding our journal review of deceased
patients, and we did not calculate the inter-observer
variations. Keeping our study to the method of classify-
ing deaths in Norway is probably also different from
clinical practice in other countries. The judgement of
the “expert” panel is also context specific, and we could
have had too strict of a definition regarding unexpected
deaths as a group. We may also have been too strict to
judge adverse events as non-preventable. All of the par-
ticipants on the panel were from Haukeland University
Hospital. Hence, we may have been less critical of our
own hospital’s performance than if we had employed an
external review group. Lethal adverse events may also
occur in patients with life threatening conditions or, e.g.,
were in a final stage of cancer. Therefore, our estimate
may be somewhat lower than the true situation; how-
ever, we do not consider this a major bias.
Based on the results from our study, we recommend
caution when analysing and drawing conclusions on the
cause of death using the random sample method of
adverse events without considering what type of patients
are being studied. In particular, using such small sample
sizes to estimate the national burden of deaths, as was
initially done by the Norwegian National Safety
Campaign, could be biased. If the primary aim is to
estimate the proportion of adverse events contributing
to death, we recommend also specifically studying the
total population of patients who actually died in the
hospital and, thereafter, analysing the causes of death in
that population.
Conclusions
We found that approximately 2% of all hospital admis-
sions in our health trust died after admission. The
majority of deaths occurred in ordinary hospital wards.
Approximately one out of four hospital deaths was con-
sidered to be unexpected and/or sudden. Of all deaths,
only a minor proportion (6%) were classified as unnat-
ural, and half of these were considered to have ≥50%
likelihood of being preventable.
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